Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene (HTT).
• Mutant huntingtin protein (mHTT) forms aggregates, disrupting neuronal function and leading to disease pathology.
• Current treatments for HD are limited, with no effective cure available.

Purpose of the Study:

• To review current therapeutic strategies for Huntington's disease.
• To discuss the mechanisms of mHTT toxicity and potential treatment targets.
• To highlight the promise of gene therapy for reducing mHTT expression.

Main Methods:

• Literature review of existing Huntington's disease treatments.
• Analysis of therapeutic approaches targeting mHTT.
• Discussion of gene therapy strategies for HD.

Main Results:

• Significant progress has been made in developing diverse therapeutic strategies for HD.
• Targeting mHTT neuronal toxicity and reducing mutant HTT gene expression show therapeutic promise.
• Gene therapy approaches offer a promising avenue for effective HD treatment.

Conclusions:

• While no cure exists, various therapeutic strategies are under development for Huntington's disease.
• Reducing mutant huntingtin protein expression via gene therapy is a key focus for future treatments.
• Continued research is essential for advancing Huntington's disease therapeutics.